BioVie Inc. BIVI
Set alert
1.37 USD -0.06 -4.20%
At close · Nov 2
1.37 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
1.32 Day range 1.43
0.964 52-week range 2.28
- YTD
- +18.10%
- 1 year
- -21.71%
- Open
- 1.41
- Prev close
- 1.43
- Mkt cap
- 11.90M
- Vol
- 120.48K
- Avg vol
- 4.59M
- EPS
- -2.90
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.32
- High
- 1.43
- Forward P/E
- -0.49
- Beta
- 0.90
- Short ratio
- 0.15
- Inst. own
- 9.99%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 10, 2025
- 50-d avg
- 2.66
- 200-d avg
- 3.68
- 1y target
- 5.00
Analyst view
Consensus: none
Price target (mean) 5.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -2.90 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -2.20 | 0.0% | 0 | 0.0% | 0 |
| Current year | -4.41 | -4.41 – -4.41 | -7.30 | +39.6% | 0 | 0.0% | 1 |
| Next year | 0.00 | 0.00 – 0.00 | -4.41 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 1, 2024 | ThinkEquity | Initiated | — | Buy |
| Nov 30, 2023 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 22, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jul 18, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| May 17, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| May 17, 2023 | Oppenheimer | Reiterated | Outperform | Outperform |
| Feb 14, 2023 | Oppenheimer | Reiterated | — | Outperform |
| Sep 28, 2022 | EF Hutton | Maintained | — | Buy |
| Jul 22, 2022 | Cantor Fitzgerald | Initiated | — | Overweight |
| Mar 17, 2022 | EF Hutton | Maintained | — | Buy |
| Mar 15, 2022 | Oppenheimer | Initiated | — | Outperform |
| Nov 30, 2021 | B. Riley Securities | Maintained | — | Buy |
| Jan 15, 2021 | B. Riley FBR | Initiated | — | Buy |